Per the NIAAA Core Resource on Alcohol, it's a first-line treatment for alcohol use disorder
[1] [2] There are pen-based workarounds, staying at the lowest strengths long term or spacing doses further apart, and we've covered how providers handle those in the Wegovy and Zepbound guides
During the item generation and discussion and clarification phases, the experts identified 14 distinct challenges: costs, supply challenges, lack of evidence, polypharmacy, barriers to prescription, lack of knowledge, adherence concerns, aversion to injection therapy, clinical inertia, titration needs, perceived health state, fear of adverse effects, lack of clinical guideline recommendations, and lack of measurable outcomes to guide therapy
Watch the full podcast: #PatientCare #WatchfulWaiting #AntibioticStewardship #InfectiousDisease #DoctorPatientTrust #HealthcareEducation #SmartMedicine #MedicalPodcast To view or add a comment, sign in Nine years leading Medical Affairs at Amicus Therapeutics taught Joseph Giuliano one thing above all: transformation starts with giving your team a clear framework to work with
